Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection that results in thousands of deaths each year, mostly in African children. The in vivo mechanisms underlying this fatal condition are not entirely understood. Using the animal model of experimental cerebral malaria (ECM), we sought mechanistic insights into the pathogenesis of CM. Fatal disease was associated with alterations in tight junction proteins, vascular breakdown in the meninges / parenchyma, edema, and ultimately neuronal cell death in the brainstem, which is consistent with cerebral herniation as a cause of death. At the peak of ECM, we revealed using intravital two-photon microscopy that myelomonocytic cells and parasitespecific CD8 + T cells associated primarily with the luminal surface of CNS blood vessels.
Introduction
Malaria, a disease caused by protozoan parasites of the genus Plasmodium, is a leading cause of morbidity and mortality in the developing world. Of the 627,000 annual deaths due to malaria, the vast majority are caused by Plasmodium falciparum infections [1] . Human cerebral malaria (HCM) is one of several clinical manifestations of severe P. falciparum infection and is diagnosed by coma and parasitemia in the absence of meningitis, hyperglycemia, and postictal state [2] . HCM is fatal in 15-30% of affected individuals [3, 4] , while an additional 10% of survivors suffer long-term neurological sequelae such as ataxia, hemiplegia, and cognitive impairment [5] . Yet, the underlying cause of HCM remains unknown.
Several characteristic pathologies are observed in the brains of patients suffering from HCM including vascular hemorrhage [6] , breakdown of the blood brain barrier (BBB) [7, 8] , and edema [9, 10] . At the cellular and molecular level, HCM is associated with an increase in systemic pro-inflammatory cytokines [11, 12] , endothelial cell (EC) activation [13] , and sequestration of parasite-infected red blood cells (iRBCs) [2] and leukocytes [8] within the brain vasculature. These conditions are hypothesized to contribute to the observed BBB disruption and cerebral edema as well as ischemia throughout the CNS [14] . However, interpretations of these HCM data are limited by the fact that most information about CNS pathology and the cellular response to P. falciparum is derived from post-mortem analyses. Although real-time in vivo imaging techniques such as MRI [9] and ophthalmoscopy [15] have been used in patients suffering from HCM, they lack the resolution needed to observe cellular dynamics in the CNS and have been used mostly to improve the fidelity of CM diagnoses. Examination of cellular dynamics in animal model systems is therefore needed to uncover mechanistic insights into HCM.
Infection of mice with Plasmodium berghei ANKA (PbA) induces a neurological disease called experimental cerebral malaria (ECM) that mirrors many of the pathological features observed in HCM. These include increased pro-inflammatory cytokines, vascular pathology, disruption of the BBB, and cerebral edema [16] [17] [18] [19] . ECM in mice is a widely used model of HCM and provides a valuable tool for elucidating the mechanisms involved in CM pathogenesis and identifying cellular and molecular targets for adjunctive therapy [20] . Leuko cell arrest is a signature of the disease [39] , but it is unclear how these cells cause neurological symptoms or why mice succumb to ECM. Using several techniques, including intravital imaging, we set out in this study to conduct an unbiased examination of how innate and adaptive immune cells contribute to cerebrovascular perturbations during ECM and to identify the cause of this fatal disease. We also sought in vivo insights into how cerebrovascular ECs respond to ECM and whether immune interactions with these cells could be therapeutically manipulated to ameliorate disease pathogenesis. Our data demonstrate that CD8 + T cells drive fatal vascular leakage during ECM, and they accomplish this by interacting in an antigen-dependent manner with cerebrovascular ECs. This results in profound BBB dysfunction and secondary death of neurons, most notably in the brainstem, which likely gives rise to autonomic dysfunction and death. ECM can be prevented by eliminating antigen presentation in cerebrovascular endothelial cells or by displacing parasite-specific CD8 + T cells from CNS blood vessels using an anti-adhesion molecule therapy.
Results

ECM is associated with recruitment of innate and adaptive immune cells to the CNS
Human cerebral malaria is associated with several hallmark pathologies in the brain parenchyma including vascular hemorrhaging, breakdown of the BBB, and cerebral edema. Similarly, we observed that mice infected with PbA were highly parasitemic, moribund, and showed evidence of profound BBB breakdown and edema at day 6 p.i. (S1A-S1E Fig) . We also observed evidence of significant vascular hemorrhaging in the brain parenchyma (S1F Fig) that was almost always associated with iRBCs (S1G Fig) . Interestingly, evidence of vascular pathology was also found in the meninges, which has not been reported previously ( Fig 1A) .
To gain insights into the immunopathogenesis of ECM, we conducted a temporal analysis of the immune subsets that arrive in the CNS as PbA-infected mice develop neurological symptoms. We used a clinical scoring system of 0 (moribund) to 20 (asymptomatic) developed by Carroll et al. [40] to assess disease severity (S1A Fig). We separately evaluated the meninges and brains of naïve, d5 p.i. (parasitemic but asymptomatic), and d6 p.i. (highly parasitemic and symptomatic) mice. This study revealed a significant increase in CD8 + T cells and Ly6C hi inflammatory macrophages/monocytes in the brains and meninges as mice developed symptoms on d6 p.i. (Fig 1B and 1C) . To monitor PbA-specific CD8 + T cells, we generated pentamers consisting of H-2D b loaded with an immunodominant PbA epitope (SQLLNA-KYL) described by Howland et al. [41] . Interestingly, PbA-specific CD8 + T cells increased in frequency and number in the spleen, meninges, and brain as mice progressed from asymptomatic (d5 p.i.) to symptomatic (d6 p.i.) (Fig 1D and 1E) . Thus, neurological symptoms during ECM are associated with the migration of Ly6C hi monocytes and parasite-specific CD8 + T cells to the CNS.
Innate immune cells accumulate within cerebral vasculature but do not cause fatal disease
Because myeloid cells are recruited to the CNS during ECM, we examined the dynamics and anatomical distribution of these cells using intravital two-photon microscopy (TPM) through a thinned skull window as described [42, 43] . We monitored the dynamics of myelomonocytic cells (monocytes and neutrophils) using lysozyme M-GFP (LysM gfp/+ ) reporter mice [44] . Consistent with our flow cytometric data Fig 1B and 1C we observed a significant increase in the number of myelomonocytic cells in symptomatic mice at d6 p.i. compared to d5 p.i. and uninfected animals. Interestingly, the myelomonocytic cells were contained almost entirely within the vasculature and were found in both the brain and periphery (ear) indicating systemic inflammation (Fig 2A) (S1-S3 Movies). These cells were also occasionally associated with vascular leakage in the brain (S2 Movie).
To determine the anatomical relationship between myelomonocytic cells and iRBCs during the development of ECM, we infected LysM gfp/+ mice with recombinant PbA expressing mCherry and OVA (PbA-OVA-mCherry) [45] . In symptomatic mice at d6 p.i., we observed fluorescent iRBCs adherent to cerebral vasculature ( Fig 2B; S3 Movie) , similar to what is found in human CM patients. We also visualized myelomonocytic cells actively phagocytosing these iRBCs while patrolling the vascular lumen ( Fig 2B; S3 Movie). In fact, we found that on average nearly 60% of the fluorescent iRBCs were associated with LysM-GFP signal at any one time. In addition to the vascular lumen, some fluorescent iRBCs localized to the perivascular spaces of intact vessels, suggesting extravasation (S4 Movie). These parasites were rapidly acquired by perivascular macrophages visualized in CX3CR1 gfp/+ mice (S4 Movie). These data indicate iRBCs were positioned on the luminal and abluminal surface of cerebral blood vessels during the development of ECM. The contribution of innate immune cells to the pathogenesis of ECM is still a matter of contention. Previous studies have either implicated monocytes and neutrophils in the pathogenesis of ECM [18, [27] [28] [29] or shown them to be irrelevant [21, 33, 35, 36] . Our flow cytometric (Fig 1) and imaging (Fig 2) data suggested that these cells might be involved in disease pathogenesis. To determine if myelomonocytic cells contribute to BBB breakdown or mortality during ECM, we depleted neutrophils with anti-Ly6G antibodies in CCR2 -/-mice (S2A Fig, which are deficient in circulating monocytes [46, 47] . This resulted in an 85% reduction of the total circulating myelomonocytic compartment. When compared to PbA-infected controls, mice lacking monocytes and neutrophils showed no preservation of BBB integrity or reduced mortality rate during ECM (Fig 2C-2E ). In addition, depletion of myelomonocytic cells did not improve clinical scores or alter parasitemia levels (S2B and S2C Fig) . Based on these results, myelomonocytic cells do not appear to play a significant role in the pathogenesis of ECM.
CD8 + T cells arrest along the CNS vasculature and cause ECM
Having ruled out myelomonocytic cells as the cause of fatal pathology during ECM, we focused on the adaptive immune response, with a specific emphasis on T cells given that mice lacking B cells are still susceptible to ECM [34] . We initiated this line investigation by conducting a series a T cell depletion experiments. On d4 p.i. PbA-infected mice were administered antibodies specific for CD8 + or CD4 + T cells (S3A Fig) and then monitored for development of ECM relative to untreated control mice (Fig 3A) . Although depletion of CD4 + T cells had no To determine the anatomical localization of activated PbA-specific CD8 + T cells within the brain at the peak of ECM, naïve B6 mice were seeded i.v. with 10 4 naïve mCerulean + OT-I T cell receptor transgenic CD8 + T cells and then infected with PbA-OVA-mCherry. Symptomatic mice were imaged 6 days later by TPM. These intravital imaging studies revealed that nearly all PbA-specific CD8 + T cells in symptomatic mice were arrested on or slowly crawling along the luminal and extravascular surfaces of cerebral blood vessels and were often associated with significant vascular breakdown. (Fig 3B; S5-S7 Movies). Interestingly, this activity was specific to the brain, as PbA-specific CD8 + T cells were not observed arresting along the vasculature in a peripheral tissue (ear) within the same mouse (Fig 3B; S5 Movie). Although PbA-specific CD8 T cells in the CNS were observed within perivascular spaces and the parenchyma, the majority appeared to be interacting with the luminal surface of blood vessels. To quantify the percentage of luminal vs. extravascular PbA-specific CD8 T cells, we created volumetric masks corresponding to the Evans blue signal in each blood vessel (Fig 3C, S8 Movie) . After applying the mask, all visible PbA-specific CD8 + T cells, including those located on the surface blood vessels, were counted as extravascular, whereas cells obscured by the mask were considered luminal (Fig 3C, S8 Movie) . We found that the vast majority of PbA-specific CD8 T cells were associated with the luminal surface of CNS blood vessels (Fig 3D) . Collectively, these data indicate that CD8 + T cells arrest along the cerebral vasculature during ECM and are responsible for the vascular pathology.
Fatal ECM is associated with severe brainstem pathology
Because PbA-specific CD8 + T cells were intimately associated with cerebral vasculature, we postulated that cytotoxic lymphocyte-mediated killing of vascular ECs might serve as the cause of BBB breakdown and death during ECM. To simultaneously assess cell death and vascular leakage in vivo, we injected naïve and symptomatic mice at d6 p.i. intravenously with propidium iodide (PI) (to label dead cells) and Evans blue (to assess vascular leakage). This assay revealed a striking pattern of pathology in all mice succumbing to ECM (Fig 4A) . Whereas evidence of cell death was observed in multiple brain regions (e.g. olfactory bulb, cortex, cerebellum, brainstem, choroid plexus), the brainstem and olfactory bulb pathology were particularly severe ( Fig 4A) . Both brain regions showed evidence of profound vascular leakage and cell death. The brainstem pathology is consistent with cerebral herniation [48] and would likely give rise to autonomic dysfunction. To determine if the PI + cells were in fact vascular ECs, we co-stained sagittal brain sections with anti-CD31 antibodies and performed quantitative analyses (Fig 4B and 4C ). Although EC death was observed in multiple brain regions during ECM, only a small fraction of the total ECs was PI + (Fig 4B and 4C) . Thus, it is unlikely that EC death is the cause of fatal disease in mice with ECM. We found a small number of PI + ECs in the brain during ECM, but the vast majority of the dead cells were unknown. Based on cellular morphology and anatomical location, we hypothesized that at least some of the PI + cells were neurons. Interestingly, co-staining with anti-NeuN antibodies revealed that nearly all of the PI + cells in the brainstem were neurons-a pattern of cell death that was unique to this brain region (Fig 4D and 4E ). Because the brainstem controls vital functions such as the cardiovascular and respiratory systems, it is likely that mice succumb to ECM due to the widespread neuronal death observed in this brain region.
Tight junction protein expression is reduced only in areas of vascular breakdown
We observed evidence of profound vascular leakage in several brain regions, including the brainstem; however, previous studies have suggested that this is not due to reduced expression of endothelial tight junction proteins [18] . We hypothesized that this negative result might be explained by a failure to directly compare tight junction (TJ) protein expression in leaking versus intact cerebral vasculature during the development of ECM. To test this hypothesis, we injected uninfected or symptomatic mice at d6 p.i. with Evans blue to locate areas of vascular leakage within the brain ( Fig 5A) . Next, we stained sagittal brain sections with antibodies (Fig 5B) . Thick sections were used in order to generate volumetric 3D masks of individual blood vessels in the frontal cortex, cerebellum, and brainstem ( Fig 5B) . This method provides a more accurate representation of claudin-5 staining over an entire blood vessel than would be obtained by performing 2D analyses on thin sections. When we quantified the intensity of claudin-5 staining on 3D reconstructed blood vessels in various regions of the brain, we consistently found reduced expression in areas of Evans blue+ vascular leakage within symptomatic mice when compared to the same areas in uninfected mice ( Fig 5C) . Furthermore, we found that claudin-5 levels in brain regions of symptomatic mice where there was no vascular leakage were comparable to the levels observed on naïve blood vessels ( Fig 5C) . We were unable to find areas without vascular leakage in the brainstem due to the extensive amount of pathology in this brain region. Thus, by comparing to leaking to intact cerebral blood vessels, we uncovered that vascular leakage is indeed associated with reduced TJ expression.
CNS ECs are selectively activated in an IFN-γ-dependent manner during ECM
We observed the PbA-specific CD8 + T cells interact heavily with cerebral vasculature during ECM, but the vast majority of ECs survive these engagements. To better understand the mechanisms guiding these interactions, we conducted flow cytometric analyses of cerebral ECs during the development of ECM and compared them to ECs extracted from a peripheral tissue (ear) (Fig 6A-6C) . By gating on live, CD45 ) molecules were all significantly increased on ECs from symptomatic mice at d6 p.i. (Fig 6A and 6B ). Elevated expression of these molecules appeared as early as d4 p.i. and usually increased further as the disease progressed ( Fig 6B) . ECs extracted from meningeal blood vessels were similarly activated (S4B Fig) . Interestingly, this EC activation phenotype was unique to the CNS, as ECs extracted from a peripheral site (ear) showed a significantly reduced expression level of adhesion and antigen presentation molecules (Fig 6C) . This is consistent with our intravital imaging data showing slow crawling and arrest of PbA-specific CD8 + T cells along cerebral, but not ear vasculature ( Fig 3B; S5 Movie). This finding also suggests that the increase in myelomonocytic cells observed in the ear vasculature of PbA-infected mice did not induce EC activation. We next sought insights into the mechanism underlying cerebral EC activation during ECM. Previous studies have shown that IFNγ-deficient mice are protected from ECM [34, 49, 50]. We confirmed these findings (S4C- S4E Fig) and hypothesized that IFNγ produced by lymphocytes recruited to the CNS might be responsible for cerebral endothelial cell activation during ECM (Fig 6B) . A link has been established between IFNγ and ICAM-1 expression in the brain during ECM, but the cell type(s) affected by the absence of IFNγ was not determined [51, 52] . To address the role of IFNγ in EC activation during ECM, we infected wild type and IFNγ -/-mice with PbA and examined EC phenotype on day 6. ECs from IFNγ -/-mice had significantly reduced levels of adhesion and antigen presentation molecules ( Fig 6D) . ECs to uninfected levels. These data correlated with a severe reduction in PbA-specific CD8 T cell accumulation in the brain, despite normal peripheral expansion and migration (S4F Fig) . Furthermore, PbA-infected IFNγ -/-mice lacked the severe vascular breakdown and brainstem neuronal cell death observed in wild type mice (Fig 6E and 6F ). These data indicate that IFNγ is responsible for cerebral EC activation during ECM and that IFNγ-deficiency likely protects mice in part by keeping ECs in a naïve state.
Late blockade of adhesion molecules disrupts PbA-specific CD8 + T cell-EC interactions and protects mice from ECM Previous studies using CBA/J mice have demonstrated that antibody blockade of LFA-1 during ECM is highly efficacious at preventing disease [17, 53, 54] . However, we have found that this treatment is ineffective in PbA-infected C57BL/6 mice. Activated CD8 + T cells express multiple adhesion molecules, including LFA-1 and VLA-4, which are ligands for ICAM-1 and VCAM-1, respectively. Given that brain ECs upregulate both ICAM-1 and VCAM-1 during ECM (Fig 6B) , we hypothesized that administration of a combination of anti-LFA-1 and anti-VLA-4 antibodies (anti-LFA-1/VLA-4) could be used to therapeutically displace PbA-specific CD8 + T cells from cerebral vasculature and prevent fatal disease. We administered this therapy on day 5. Movie). A significant reduction in the frequency of PbA-specific CD8 + T cells associated with brain vasculature was observed for the entire viewing period after anti-adhesion therapy ( Fig  7B) , which was not seen in mice treated with istoype control antibodies (Fig 7C) . Interestingly, the frequency of PbA-specific CD8 + T cells in the parenchyma and perivascular spaces was not affected by blocking adhesion molecules (Fig 7D) , suggesting that intravascular CD8 + T cell interactions are the ones responsible for fatal pathology during ECM. Furthermore, disruption of luminal CD8 T cell interactions with brain ECs via adhesion molecule blockade also prevented the death of brainstem neurons observed in isotype control treated mice (Fig 7E and  7F) . In concert, these data show that blocking adhesion to ICAM-1 and VCAM-1, which are highly expressed on brain ECs during ECM, prevents PbA-specific CD8 + T cells from arresting along cerebral vasculature and rescues mice from fatal pathology and disease.
Antigen presentation by cerebral ECs leads to PbA-specific CD8 T cell arrest and fatal disease Mice were seeded with mCerulean + OT-I T cells and then infected with PbA-OVA. When these mice became symptomatic on day 6 post-infection, we intravenously injected yellow whereas the wild type controls succumbed to disease as expected ( Fig 8F and S6C Fig) . D b-/-BM chimeras were resistant to ECM, we set out to determine whether they were also free from brainstem pathology normally associated with this disease ( Fig 4A, 4D and 4E ). Brains from wild type BM chimeras injected with PI and Evans blue at the peak of disease revealed extensive vascular leakage and cell death in the brainstem ( Fig  9A) . However, K b-/-D b-/-BM chimeras were free of pathology at this same time point (Fig 9A) .
Nearly all of the dead cells in the brainstems of wild type BM chimeras were neurons, whereas brainstem neurons in K b-/-D b-/-BM chimeras were unaffected (Fig 9B and 9C) . These results suggest that antigen presentation by brain ECs, which fosters increased interactions with PbAspecific CD8 T cells, leads to severe brainstem pathology during ECM. 
Discussion
The pathological mechanisms underlying HCM are not entirely understood. Because ECM shares many of the pathological features of HCM, we set out to uncover novel mechanistic insights into the immunopathogenesis of this disorder. We made several important observations that significantly advance our understanding of cerebral malaria. Studies have shown that CM in humans and rodents is associated with BBB breakdown, edema, and hemorrhaging. During the peak of ECM, we noted that the meninges in addition to the brain parenchyma show evidence of profound vascular pathology, and this was associated a reduction in tight junction protein expression. Importantly, death from ECM is linked to marked vascular leakage and neuronal cell death in the brainstem, which is consistent with the edema and subsequent cerebral herniation recently observed in children with HCM [9] . Mechanistically, we uncovered that this fatal disease is caused by the activities of parasite-specific CD8 + T cells operating along cerebral blood vessels. As the disease developed, cerebrovascular ECs were highly activated by IFNγ, which promoted induction of cell adhesion and antigen presenting molecules. This in turn facilitated cognate peptide-MHC I dependent engagement by parasitespecific CD8 + T cells primarily on the luminal surfaces of cerebral blood vessels. The pathological significance of these interactions was demonstrated in mice rendered genetically deficient in their ability to present antigen in MHC I on ECs. These mice had reduced cerebrovascular engagement by CD8 + T cells and were resistant to fatal disease. Lastly, therapeutic administration of antibodies specific for VLA-4 and LFA-1 rapidly displaced CD8 + T cells from cerebral blood vessels and promoted survival, thus providing a simple yet effective means to treat this disease.
One of the most interesting findings in our study is the pathology observed in mice with severe ECM. By simultaneously injecting Evans blue and propidium iodide, we were able to evaluate the relationship between vascular leakage and cell death in mice succumbing to ECM. While vascular leakage was notable through the brain and meninges, the most striking areas of pathology were the olfactory bulb and brainstem. Vascular pathology was previously reported in the olfactory bulb of mice with ECM and linked to a decline in their sense of smell [56] . The severe pathology observed in the brainstem, however, is more relevant from the perspective of survival. Profound vascular leakage and neuronal cell death was seen in all mice succumbing to ECM and was associated with reduced expression of the tight junction protein, claudin-5. Sudden neuronal depolarization and death in this brain region would cause cardiorespiratory failure as observed in other neurological disorders [57, 58] . Importantly, a recent magnetic resonance imaging (MRI) study revealed evidence of severe brain swelling in 84% of children with HCM [9] . Brainstem herniation was also demonstrated in fatal instances of this disease. Our ECM results are consistent with brainstem herniation and pathology being the cause of death, which is supported by a MRI study showing significant displacement of the cerebellum and brainstem in mice with fatal ECM [48] . Therefore, increased intracranial pressure leading to cerebral herniation is the likely cause of death in rodents and children with CM.
To gain insights into the mechanisms that give rise to fatal edema during CM, we examined the activities of innate and adaptive immune cells. Our flow cytometric and two-photon imaging data revealed that ECM is associated with recruitment of innate and adaptive immune cells , and within the bar, the red coloration shows the proportion that are also NeuN + (mean ± SD; n = 4 mice per group; 1 brain section per mouse; 4 images per brain section). Asterisks denote a statistically significant difference from all other groups (***P < 0.05). Fig  6C) [69], we have provided direct evidence that this is driven by IFNγ (Fig 6D) . Because antigen recognition occurs on cerebral ECs, it is likely that T cell-derived IFNγ plays a major role in the activation of the CNS vasculature. However, it remains to be determined why antigen presentation and T cell engagement occurs primarily on cerebral blood vessels and not vasculature residing in a peripheral site such as the ear. Features of the infecting parasite are also likely to contribute to severe disease. In children, one particular var gene product expressed on the iRBC surface to endothelial protein C receptor (EPCR) is associated with CM [70, 71] , and brain autopsies of Malawian children who died from CM showed loss of EPCR at sites of sequestered iRBCs [72] . In mice, ECM-inducing PbA differs by only 18 non-synonymous mutations in open reading frames from the NK65 parasite that does not cause ECM, suggesting that these parasite genes may contribute to the unique brain pathology during ECM. The localization of parasite-specific CD8 + T cells along cerebral vessels [39] does not alone prove that these cells are engaged in cognate peptide MHC I interactions or that these interactions are important for disease development. To demonstrate the specificity of these interactions, we conducted several lines of investigation. We demonstrated previously that CTL division could be advanced by peptide MHC I interactions in the virally infected meninges [55] . Interestingly, we observed a similar pattern of parasite-specific CD8 + T cell division in the lumen of cerebral blood vessels during ECM, suggesting antigen-specific interactions. The specificity of the vascular CD8 + T cell interactions was proven by injecting anti-K b -SIINFEKL antibodies intravenously during ECM. This increased the velocity of luminal parasite-specific CD8 + T cells, indicating that the interactions with ECs were in fact antigen specific. This conclusion was further supported by the preferential arrest of parasite-specific CD8 + T cells on cerebral vasculature when compared to bystander CD8 + T cells of an irrelevant specificity.
Lastly, the functional importance of the interactions was demonstrated by removing MHC I from the stromal compartment through the generation of bone marrow chimeras. Expression of MHC I on the hematopoietic system but not stromal cells such as vascular endothelium significantly reduced parasite-specific CD8 + T cell arrest on cerebral ECs and promoted survival. however, genetic studies offer some clues regarding their involvement in this disease. For example, resistant vs. susceptibility to HCM has been linked to specific human leukocyte antigen class I alleles [74, 75] . In addition, the CD8 T cell chemoattractant, CXCL10, is a strong biomarker for HCM [76] [77] [78] , and a genetic polymorphism that elevates CXCL10 levels was linked to an increased incidence of HCM [79] . Importantly, CXCL10 blockade or deficiency is partially protective against development of ECM [25, 26]. It remains to be determined whether CD8 + T cells are definitively involved in the pathogenesis of HCM, but further studies are warranted given the similarities between HCM and ECM. Without knowing the specificity of disease-inducing parasite-specific T cells, it would be difficult to therapeutically target these cells during CM. Thus, we surmised that a non-specific displacement of T cells from the cerebral vasculature would provide a more effective means to thwart this disease. We demonstrated that late blockade with antibodies against LFA-1 and VLA-4 completely prevented development of ECM, which is consistent with other studies showing the effectiveness of adhesion molecule blockade in this model [17, 53, 54] . However, the mechanism by which this therapy prevented disease was unclear. Using intravital imaging, we observed that anti-adhesion molecule therapy completely disengages CD8 + T cells from the CNS vasculature at the peak of disease without affecting the number of extravascular CD8 + T cells. These data indicate that this disease can be treated by interfering with luminal interactions between CD8 + T cells and cerebrovascular ECs. Natalizumab (anti-VLA-4) and Efaluzimab (anti-LFA-1) are both FDA approved drugs used to treat human inflammatory diseases [80] [81] [82] , opening the possibility of an expedited intervention in patients with HCM. It would be important to begin treatment in patients with edema prior to the development of cerebral herniation, which would result in irreversible brainstem pathology.
In conclusion, we have provided the first in vivo evidence detailing how CD8 + T cells cause ECM. Parasite-specific CD8 + T cells engage CNS ECs in an antigen-dependent manner, which leads to profound vascular breakdown (associated with alterations in tight junction protein expression), edema, loss of brainstem neurons, and subsequent death. Despite CTL engagement, we observed little evidence of EC death during ECM. We therefore hypothesize that CD8 + T cells use a noncytopathic mechanism to disrupt cerebrovascular EC tight junctions.
This signifies that the disease is reversible up to the point when severe edema gives rise to cerebral herniation and death of brainstem neurons (an irreversible event). The reversibility of the disease is demonstrated by the effectiveness of late anti-adhesion molecule blockade. Because many patients with CM likely arrive in the hospital with active BBB breakdown, effective therapies need to target parasite acquisition by ECs and subsequent CD8 + T cell engagement. In addition to anti-malarial drugs and supportive care, consideration should also be given to therapeutics that interfere with T cell function / metabolism [83, 84] or that temporarily displace these cells from cerebral vasculature (e.g. anti-VLA-4 / LFA-1). A reduction of parasite burden in combination with a transient disruption of T cell activity should give the BBB sufficient time to repair and for neurological disease to subside. , B6 actin-mCerulean, and B6 actin-YFP were also bred and maintained at the NIH. CX3CR1 gfp/+ mice were generated by crossing B6 mice with CX3CR1 gfp/gfp mice. Actin-mCerulean and actin-YFP mice were made as described below. YFP + P14 and mCerulean + OT-I mice were derived from the following F1 crosses:
Materials and Methods
actin-YFP x P14 and actin-mCerulean x OT-I, respectively. All mice bred in house were confirmed to be on a pure C57BL/6J background by SNP analysis (Charles River).
Transgenic mouse generation
All transgenic mice were generated by the National Institute of Mental Health (NIMH) Transgenic Core Facility. Transgenic mice expressing monomeric cerulean (mCerulean) under the chicken β-actin promoter were generated as described [87] by first PCR amplifying the entire 717 bp mCerulean coding region from the pCMV-mCerulean vector (Addgene) using primers (fwd: 5'ATATATGAATTCGCCACCATGGTGAGCAAGGGCGAGG3'; rev: 5'ATATATCTC GAGTTACTTGTACAGCTCGTCCATG3') containing EcoRI and XhoI restriction sites. This cDNA was cloned into the same sites following removal of the GFP sequence from the pCAG-GFP vector (Addgene). The resultant plasmid was digested with Sal I / HindIII, and a 2925 bp fragment containing the CMV early enhancer/chicken β-actin (CAG) promoter, mCerulean, and PolyA sequence was prepared for microinjection into the pronuclei of fertilized mouse eggs. Mice expressing the Venus variant of yellow fluorescent protein (YFP) under the CAG promoter were generated in a similar manner. The entire 717 bp coding sequence for YFP was PCR amplified using the aforementioned primers and cloned into pCAG-GFP following removal of GFP with EcoRI and XhoI. A 2925 bp fragment consisting of the CAG promoter, YFP, and a PolyA sequence cut with Sal I / HindIII and prepared for microinjection.
To generate all transgenic mice, linearized constructs were injected into C57BL/6J eggs. Following selection of transgene positive founder lines, all mice were backcrossed one additional generation onto C57BL/6J background before intercrossing.
Parasites and infections
PbA was maintained and used as previously reported [83] . PbA.OVA::mCherry hsp70 (PbA-OVA-mCherry) parasites were kindly provided by C. Janse and S. Khan [45] . PbTg (PbA-OVA-GFP) parasites were kindly provided by W. Heath [38] . All mice were infected intraperitoneally (i.p.) with 10 6 parasitized red blood cells (pRBCs). Parasitemia was determined by Giemsa-stained thin blood smear or by flow cytometry as described [88] . Mice were monitored daily for neurological symptoms of ECM using a quantitative scale as described [40] . For survival studies, mice were euthanized upon reaching a score of 0. For LCMV infections, mice were injected with 10 5 plaque forming units of LCMV Armstrong 53b strain i.p.
BBB integrity assay
Mice were i.v. injected with 20mg Evans blue (Sigma) per kg body weight at the indicated time points p.i. After 4 hours, brains were extracted following saline perfusion and then processed as described previously [42] .
Brain water content assay
Brain water content was measured as previously described [19] . Weights of brains removed at indicated time points were compared to the dry weight after overnight incubation at 80˚C.
Immunohistochemistry
Mice were anesthetized with chloral hydrate and perfused with 4% paraformaldehyde in PBS for H&E analysis, 10% neutral buffered formalin (NBF) for meningeal whole mounts, or 2% NBF in PBS for all other immunohistochemical stains. For meningeal whole mounts, skull caps were removed and incubated overnight in 10% NFB. Following a brief wash, meninges (including dura, arachnoid, and partial pia layers) were carefully removed from the bone with fine-tipped forceps and placed in PBS + 2% fetal bovine serum (FACS buffer) at 4˚C and stained with primary antibody overnight. After a brief wash, the meninges were stained with secondary antibodies for 1 hr at room temperature, followed by another brief wash and then a DAPI stain for 5 min. The meninges were placed in mounting medium on a glass slide, spread out and flattened with forceps, and cover-slipped. Brain tissues were extracted following perfusion and incubated either 2 hours for TJ stains or overnight for all other stains in the same solution with which they were perfused. After a brief wash in PBS, brain tissues were incubated in 30% sucrose in PBS for 24 hours. H&E staining was performed by HistoServe, Inc. For all other stains, tissues were frozen in Tissue-Tek optimal cutting media (Thermo Fisher Scientific). A Leica CM1850 cryostat was used to cut 40 μm thick tissue sections for TJ staining or 20 μm sections for all other stains. Primary stains were performed overnight at 4˚C, and secondary and tertiary stains were performed for 1 hr at room temperature with 3 x 5 min washes after each stain. DAPI (Sigma) was added for 5 min at RT to label cell nuclei. Following staining, 1 drop of FluorSave Reagent (Calbiochem) was added to each section before addition of a coverslip. The following primary antibodies were used: anti-Claudin-5 Alexa Fluor 488 (4C3C2) (Thermo Fisher Scientific) (1:100), polyclonal anti-laminin (Abcam) (1:200), antiNeuN (A60) (EMD Millipore) (1:250), polyclonal anti-PECAM-1 (CD31) (EMD Millipore) (1:40), and anti-TER119 (Biolegend) (1:200). All secondary antibodies and staining reagents used for immunohistochemistry were purchased from Jackson ImmunoResearch including anti-rat Alexa Fluor 647, anti-goat Rhodamine Red-X, biotin anti-goat, biotin anti-rabbit, streptavidin Alexa Fluor 488, and streptavidin Rhodamine Red-X. All secondary antibodies were used at a concentration of 1:500 with the exception of streptavidin conjugates, which were used at a concentration of 1:1000. H&E images were acquired using a Nikon Eclipse Ci microscope with 4x/0.2 NA and 40x/0.75 objectives. Fluorescent images were acquired using an Olympus FV1200 laser scanning confocal microscope equipped with 405, 458, 488, 515, 559, and 635 laser lines, 4 side window PMTs for simultaneous 4 channel acquisition, and 4x/ 0.16 NA, 10x/0.4 NA, 20x/0.75, 40x/0.95, and chromatic aberration corrected 60x/1.4 NA objectives. For cell death analyses, 10-12 0.4 mm 2 field images were collected from the brain sections of each mouse. Each field was chosen at random within one of four brain regions: olfactory bulb, cerebrum, cerebellum, and brainstem. Images were analyzed using Imaris 7.6.4 software. Only cells with PI staining throughout the nucleus were counted as dead. To determine co-localization of PI and NeuN, PI + nuclei were first identified and labeled using the spots function with Imaris software. ) were captured by confocal microscopy from each brain region per mouse. Three to four z-stacks were captured from areas with and without Evans blue leakage. Images from the corresponding brain regions of uninfected mice were also collected. Within each group, we then quantified the intensity of claudin-5 expression on 30-32 blood vessels as described previously [89] . Briefly, using Imaris 7.6.4 software, contours were generated around individual blood vessels based on CD31 staining and used to create a 3D surface. The claudin-5 intensity per unit area of an individual blood vessel within this surface was then calculated as follows: (total # voxels x claudin-5 MFI) / total surface area of vessel.
In vivo cell death assay
Mice were injected with 200μg Evans blue dye i.v. for one hour and 50μg propidium iodide (Invitrogen) i.v. for 30 minutes. Mice were anesthetized, perfused, and brain tissue was processed as described above.
Mononuclear cell isolation
Anesthetized mice received an intracardiac perfusion with PBS to remove all blood leukocytes other non-adhered cells. Single-cell spleen suspensions were prepared by mechanical disruption through a 100 mm mesh barrier followed by RBC lysis with Ack lysis buffer (0.15M NH 4 Cl, 10mM KHCO 3 , 0.1mM EDTA). Leukocytes were isolated from the meninges, using forceps to gently separate them from the underside of skull cap (exactly as performed for immunohistochemistry whole mounts) followed by enzymatic digestion in 2mg/ml collagenase D (Roche) + 50 mg/ml DNase (Roche) in RPMI for 30min at 37˚C. Leukocytes were isolated from the brain as described [90] . EC isolation was adapted from [91] . Briefly, whole meninges and minced brains from perfused mice were enzymatically digested in 0.8mg/ml Dispase II + 0.2mg/ml Collagenase P + 0.1mg/ml DNase (all Roche) in RPMI at 37˚C for 15 min with gentle shaking followed by 15 min of mechanical comminution at 37˚C. Following digestion, supernatants were isolated and washed. Meningeal ECs were ready for staining but brain EC preps were resuspended in a 40% Percoll (GE Healthcare) gradient in HBSS and centrifuged to remove excess myelin.
Flow cytometry
Surface staining and Fc blocking was performed as described [90] . Dead cells were excluded from the analysis by using the LIVE/DEAD fixable Blue Cell Staining kit (Invitrogen). The following antibodies and reagents from BioLegend were used: CD4 PE (RM4-5), CD8a APC (53-6.7), CD8β. min at room temperature before surface staining as described above. PbA-specific CD8 + T cells were also identified by IFNγ production following in vitro stimulation with SQLLNAKYL peptide. Briefly, 2 x 10 6 splenocytes from the denoted mice were incubated with 1μg/ml SQLLNAKYL peptide (AnaSpec), 100U/ml IL-2 (NIH), and 10μg/ml BFA (Sigma) in RPMI complete media at 37˚C for five hours. To detect intracellular IFNγ production, single cell suspensions were surface stained as described above, treated with cytofix/cytoperm (BD), and then stained intracellularly with anti-IFNγPE/Cy7 (XMG1.2) (BioLegend). Samples were acquired using an LSRII flow cytometer (BD), and data were analyzed using FlowJo software version 9.7.2 (Tree Star).
Cell depletion/blocking studies
All antibodies used for cell depletion and blocking assays were purchased from BioXcell. Mice were depleted of neutrophils by injecting 500 μg of anti-Ly6G (clone 1A8 
Two-photon microscopy
Mice were anesthetized and thin skull windows were prepared as previously described [42, 43] . Mice were injected with 5 μl Qdot655 (BD) or 50 μg Evans blue where indicated to visualize blood vessels. 4D datasets were acquired using an SP5 two-photon microscope (Leica) equipped with two Mai Tai HP DeepSee lasers (SpectraPhysics), an 8,000-Hz resonant scanner, a 20×/1.0 NA objective, an NDD4 detector array, and a custom-environment chamber. Simultaneous excitation and detection of multiple fluorophores was achieved using custom dichroic mirrors (Semrock) and by tuning one laser to 905 nm and the other to 990 nm. All imaging studies focused on the meninges and superficial neocortex. Imaging data were processed with Imaris 7.6.4 software. A surface was created for each CNS blood vessel and PbA-specific CD8 + T cells located within that surface (vessel lumen) were quantified, whereas T cells residing outside the surface (perivascular or parenchymal) were quantified separately. Mean track velocities (μm/min), arrest coefficients (proportion of time a cell spent arrested <2 μm/min), and arrest duration (the total amount of time a cell spent arrested <2 μm/min) were calculated for all individual luminal PbA-specific CD8 + T cell tracks using Imaris 7.6.4 and T Cell Analyzer software (TCA 1.7.0; Strathclyde Institute of Pharmacy and Biomedical Sciences). All time lapses used for these analyses were at least 40 minutes in length.
Bone Marrow (BM) chimeras
BM was harvested from femurs and tibias of Ly5.1 mice and 5x10 6 BM cells were i.v. injected into recipient mice following a lethal irradiation dose of 900 RAD. Mice received antibiotics in drinking water for 4 weeks following irradiation and were allowed 8 weeks to fully reconstitute bone marrow and donor peripheral cells.
Statistical analysis
Statistical analyses for data were performed using a Student's t test (two groups) or ANOVA (more than two groups) in Prism 6 (GraphPad Software). Groups were considered statistically different at a p value of <0.05. All data are displayed as the mean ± SD.
Ethics statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the NINDS Animal Care and Use Committee (Protocol Number: 1295-14).
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